Page 44 - 22-0424
P. 44

The International Journal of the Royal Society of Thailand
              Volume XI - 2019



              severe disability and early death in affected individuals due to progressive loss
              of neurons in the brain and spinal cord. The process is associated with genetic
              variation, environment, lifestyle, infection, etc. (Strafella, et al., 2018).



              Important steps in precision medicine in neurological disease

                      1.  Comprehensive genetic assessment
                              Clinical and genetic evaluation are critical for establishing the
                        diagnosis in both common and uncommon conditions. New techniques
                        in microarray, next generation sequencing (NGS), genome-wide
                        associated studies (GWAS) will help identifying specific mutations in
                        common disease and genetic variation (polymorphism) in general
                        population. This information will certainly increase the diagnostic
                        certainty and define population at risk for disease prevention. (Tan,
                        et al, 2016).

                      2.  Classification
                              Genetic information will provide more accurate disease classification,
                        instead of a clinical classification which is now commonly used.
                        Homogeneity in study population will aid in study design to reduce
                        bias and confounding factors and finally lead to better result.

                      3.  Biomarkers
                              Biomarkers are more important than ever in doing clinical
                        research. It can be surrogate or final outcome in both short and long term
                        studies. In neurological disease, there are blood based or CSF based
                        biomarkers, clinical neurophysiology, MRI scan or function neuroimaging.
                        These modalities can also track the changes in long term study and
                        define the natural history in many neurodegenerative disease.

                      4.  New therapeutic strategies
                              Overall updated information will lead to new therapeutic strategies
                        to slow or stop disease progression, especially neuronal degeneration.
                        More specific or tailored-made medications or interventions are more
                        commonly used toward personalized medicine concept.











              38                                               Precision Medicine in Neurological diseases




                                                                                                  11/7/2565 BE   13:27
       _22-0424(037-046)5.indd   38                                                               11/7/2565 BE   13:27
       _22-0424(037-046)5.indd   38
   39   40   41   42   43   44   45   46   47   48   49